Latest news

Filters
July 29, 2003

Debiopharm S.A. and Dyax Corp. granted European Orphan Drug Status for EPI-hNE4 (DX-890) for Cystic Fibrosis Indication

Read more
July 24, 2003

H3 Pharma Inc. announces important step in bringing SANVAR® (vapreotide) to U.S. market

Read more
July 2, 2003

H3 Pharma Inc. Licenses in Sanvar ® (vapreotide) from Debiopharm S.A.

Read more
June 4, 2003

DEBIOPHARM S.A. licenses-in a compound from Genodyssee S.A.

Read more
January 16, 2003

Debiopharm S.A. provides funding to Tulane University

Read more
November 19, 2002

Debiopharm S.A. announces a patent application on a hydrosoluble prodrug of cyclosporin A

Read more
October 24, 2002

Debiopharm S.A. licenses-in new technology to turn injectable macromolecular drugs into oral formulations

Read more
September 12, 2002

Debiopharm and Biolex sign collaboration

Read more
August 27, 2002

Debiopharm extends its collaboration with Sanofi-Synthélabo on Eloxatin®

Read more